Post by Stan Kalinin

Leadership in Life Sciences: Johannes K. Mühl (ex Myriad, Pfizer and Zimmer Biomet Senior Finance Executive.) - How different are financial departments in large and medium sized organizations? - How to make a positive impact as a Head of FP&A on business performance but not neglecting culture and people? - How to make tough decisions and still create value for Investors? - What is it like to be the part of an pre- and post M&A deal and how to make it a success for all stakeholders? - How does finance influence and boost innovation in the Life Sciences sector? Johannes K. Mühl has spent more than 20 years in the MedTech and Biotech industries in various executive positions including Senior Financial Controller at Zimmer Biomet, LEA Project Manager M&A and Business Partner Vaccines at Pfizer, Director of FP&A and Director Finance and Commercial Insights at Myriad Genetics and CFO at several Biotech ventures most recently, he will uncover the above topics in this Q&A with Stan Kalinin from Pedersen & Partners.